Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses

被引:195
作者
Mathur, RK [1 ]
Awasthi, A [1 ]
Wadhone, P [1 ]
Ramanamurthy, B [1 ]
Saha, B [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
关键词
D O I
10.1038/nm1045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages play host to Leishmania major, a parasite that causes leishmaniasis in 500,000 people annually. Macrophage-expressed CD40, a costimulatory molecule 1, induces interleukin-12 (IL-12)-dependent and interferon-gamma (IFN-gamma)-dependent host-protective immune responses to Leishmania and other intracellular pathogens(2-6). Paradoxically, IL-10, another CD40-induced cytokine in macrophages(7), promotes Leishmania infection(8). How CD40 signaling regulates the secretion of these two counteractive cytokines remains unknown. Here we show that weak CD40 signals induce extracellular stress-related kinase-1/2 (ERK-1/ 2)-dependent IL-10 expression, whereas stronger signals induce p38 mitogen-activated protein kinase (p38MAPK) dependent IL-12 production. p38MAPK and ERK-1/ 2 therefore have counter-regulatory actions. Leishmania skews CD40 signaling toward ERK-1/ 2, inducing IL-10, which inhibits activation of CD40-induced p38MAPK and expression of inducible nitric oxide synthase-2 (iNOS-2) and IL-12. ERK-1/ 2 inhibition or IL-10 neutralization restores CD40-induced p38MAPK activation and parasite killing in macrophages and the BALB/c mouse, a susceptible host. These data uncover a new immune evasion strategy, whereby Leishmania differentially modulates CD40-engaged, reciprocally functioning signaling modules, and provide a new conceptual framework for immune homeostasis.
引用
收藏
页码:540 / 544
页数:5
相关论文
共 33 条
  • [1] CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response
    Awasthi, A
    Mathur, R
    Khan, A
    Joshi, BN
    Jain, N
    Sawant, S
    Boppana, R
    Mitra, D
    Saha, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08) : 1037 - 1043
  • [2] Belkaid Y, 1998, EUR J IMMUNOL, V28, P1389, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt
  • [3] 1389::AID-IMMU1389&gt
  • [4] 3.0.CO
  • [5] 2-1
  • [6] The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
    Belkaid, Y
    Hoffmann, KF
    Mendez, S
    Kamhawi, S
    Udey, MC
    Wynn, TA
    Sacks, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) : 1497 - 1506
  • [7] PARALLEL SIGNAL-PROCESSING AMONG MAMMALIAN MAPKS
    CANO, E
    MAHADEVAN, LC
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (03) : 117 - 122
  • [8] Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice
    Carrera, L
    Gazzinelli, RT
    Badolato, R
    Hieny, S
    Muller, W
    Kuhn, R
    Sacks, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 515 - 526
  • [9] MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation
    Clayton, AL
    Mahadevan, LC
    [J]. FEBS LETTERS, 2003, 546 (01) : 51 - 58
  • [10] T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation
    Crawley, JB
    Rawlinson, L
    Lali, FV
    Page, TH
    Saklatvala, J
    Foxwell, BMJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) : 15023 - 15027